APOB and metabolic syndrome: Dyslipidemia in CKD patients is characterized by dysregulation of the synthesis and activity of HDL-C and of the metabolism of triglyceride rich apolipoprotein B containing lipoproteins, which lead to the elevated plasma triglyceride and depressed HDL-C levels17.